Related Experiment Videos
[Detection of HIV-1 antigen--determination using 3 different test systems]
F Düzgün1, N Dickgiesser, D Schuster
1Institut für Medizinische Mikrobiologie und Hygiene, Klinikum der Stadt Mannheim, Mannheim.
Klinische Wochenschrift
|March 1, 1988
Summary
Three enzyme immunoassays (EIAs) for detecting human immunodeficiency virus 1 (HIV-1) antigen showed variable results. Differences in HIV-1 antigen detection may stem from assay types and capture antibodies used.
Area of Science:
- Medical Diagnostics
- Virology
- Immunology
Background:
- Human immunodeficiency virus 1 (HIV-1) infection diagnosis relies on detecting viral antigens and antibodies.
- Enzyme immunoassays (EIAs) are common diagnostic tools for HIV-1 detection.
- Variability in EIA performance can impact diagnostic accuracy.
Purpose of the Study:
- To compare the sensitivity, handling, and clinical correlation of three different EIAs for HIV-1 antigen detection.
- To identify discrepancies in HIV-1 antigen detection among different EIA kits.
Main Methods:
- Examination of 51 human sera for HIV-1 antigen using three distinct EIAs (Abbott, Organon, Dupont).
- Comparative analysis of assay sensitivities, ease of use, and correlation with HIV-1 infection stages.
- Evaluation of discrepancies in HIV-1 antigen detection across the three EIA methods.
Main Results:
- All three EIAs agreed on 6 sera positive for HIV-1 antigen and 42 negative.
- Three sera yielded discordant results across the EIAs.
- Specific differences were noted, with one EIA detecting antigen in one serum, and another EIA detecting it in two others.
Conclusions:
- Discrepancies in HIV-1 antigen detection by EIAs may be attributed to variations in assay procedures (indirect vs. direct).
- Differences in capture antibodies (anti-p24 vs. polyvalent) likely contribute to observed performance variations.
- Further investigation into EIA methodologies is warranted for optimal HIV-1 antigen detection.